Orphan Drugs Market to Reach USD 340.84 Billion by 2027; Increasing Number of Regulatory Approvals will Contribute to Market Growth, says Fortune Business Insights™

    NEXT STORY
    Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors
    PREV STORY
    TELUS launches newest Health for Good mobile clinic to support Toronto’s most marginalized citizens
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe

    author_avatar
    NASDAQ Market News

    Elsalys Biotech : New studies confirm anti-CD160 potential in ophthalmology

    New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases Efficacy and safety ...

    author_avatar
    NASDAQ Market News

    Sharps Compliance Reports Fiscal 2019 Third Quarter Results

    author_avatar
    NASDAQ Market News